Range Financial Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Range Financial Group's GILD Position: Q2 2026 in Review
Range Financial Group reduced its Gilead Sciences (GILD) stake by 85% in Q2 2026, selling an estimated $1.64M and leaving 2,243 shares worth $283K. The position accounts for 0.08% of the portfolio, ranked #187.
Range Financial Group first reported a position in GILD in Q1 2021 and has held it in 22 quarters since. The position peaked at $2.05M in Q1 2026. 1,095 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Range Financial Group held 2,243 shares of Gilead Sciences worth $283K as of Q2 2026.
- Range Financial Group sold 12,437 Gilead Sciences shares in Q2 2026, an estimated $1.64M.
- Gilead Sciences made up 0.08% of Range Financial Group's portfolio in Q2 2026, its #187 holding.
- Range Financial Group first reported a position in Gilead Sciences in Q1 2021 and has held it in 22 quarters since.
- Range Financial Group's Gilead Sciences position peaked at $2.05M in Q1 2026.
- 1,095 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Range Financial Group's 13F filing for Q2 2026, filed 15 Jul 2026.